Ignyte Acquisition

General Information

We currently intend to focus on target companies in the life sciences, biotechnology and healthcare sectors. 

We are led by our Chairman and Co-CEO David Rosenberg, who is the Co-CEO and co-president of Ladenburg Thalmann & Co. Inc., or Ladenburg; our Co-CEO David J. Strupp, Jr., who is the head of healthcare investment banking at Ladenburg, and our Chief Financial Officer Steven Kaplan, who is head of capital markets at Ladenburg. The team has worked together at Ladenburg since 2012. Ladenburg is a growth-focused boutique investment bank with experience providing capital markets and advisory services to public and private life sciences companies. (Note: This is a blank-check company (SPAC, or special-purpose acquisition company) formed under the laws of Delaware.)

(Note: Ignyte Acquisition priced its IPO on Jan. 27, 2021, according to its terms in the prospectus: 5 million units at $10 each to raise $50 million.)

Employees: 0
Founded: 2020
Contact Information
Address 640 5th Avenue 4th Floor New York, New York 10019
Phone Number (212) 409-2000
Web Address
View Prospectus: Ignyte Acquisition
Financial Information
Market Cap $63.5mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol IGNYU
Exchange NASDAQ
Shares (millions): 5.0
Price range $10.00 - $10.00
Est. $ Volume $50.0 mil
Manager / Joint Managers EarlyBirdCapital, Inc.
CO-Managers -
Expected To Trade: 1/28/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change